Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
Item-specific, tested applications and recommended dilutions are not provided for this product. Refer to the CoA/Spec Sheet for definitive protocols. The following are general starting points for mouse monoclonal antibodies; adjust empirically and validate.
Western blot (general):
Starting dilution 1:500–1:2000 in TBST + 1–5% BSA or milk; incubate 1 h RT or overnight at 4°C. Use anti-mouse secondary HRP (or appropriate conjugate).
IHC (general):
Antigen retrieval as appropriate (citrate pH 6.0 or EDTA pH 8–9); block endogenous peroxidase for HRP systems. Start at 1:100–1:500.
IF/ICC (general):
Permeabilize with 0.1–0.3% Triton X-100 if intracellular target; block with serum/BSA; start at 1:200–1:1000.
ELISA (general):
Coating antigen 0.5–2 µg/mL; primary antibody titration 0.1–1 µg/mL or 1:1,000–1:10,000 depending on affinity.
IP (general):
1–5 µg antibody per mg lysate protein; couple to Protein G or A (mouse IgG subtype-dependent).
Note: Conjugation state, isotype, and buffer/excipient content for this item are not specified; adjust secondary and purification media accordingly.
Biological Roles
Focus: the ACY3 target (aminoacylase-3) rather than the antibody itself.
ACY3 function (literature): ACY3 is a zinc-dependent aminoacylase implicated in the hydrolysis of N-acylated amino acids and certain mercapturic acids, contributing to xenobiotic and endogenous metabolite processing. It belongs to the metallo-dependent hydrolase superfamily and is localized predominantly in cytosolic compartments in several tissues.
Pathways (literature): Involved in amino acid/peptide catabolism and detoxification pathways, including the processing of N-acetylcysteine conjugates derived from phase II metabolism. Expression patterns can be tissue-specific and regulated developmentally and by metabolic state.
Research utility of anti-ACY3 antibodies (general):
Detection and relative quantification of ACY3 protein levels in cells/tissues via WB, IHC/IF, and ELISA.
Immunoprecipitation of ACY3 to study interacting partners and post-translational modifications.
Assessment of subcellular localization by IF/ICC when properly validated.
Note: Species reactivity, epitope mapping, and validated applications for this specific product are not specified; consult the CoA/Spec Sheet. No medical or diagnostic claims are made—this reagent is for research use only.
Buffer Applications
Antibody performance depends strongly on buffer composition. Item-specific formulation and suggested diluent are not provided; the following is general guidance for mouse monoclonal antibodies.
Common working buffers (general):
Dilution: PBS or TBS, pH 7.2–7.6, with 0.1% BSA as a carrier and 0.05–0.1% Tween-20 for WB/ELISA to reduce nonspecific binding.
Blocking: 3–5% nonfat dry milk or BSA in TBST/PBST for WB; serum-based blocks may be preferred for IHC/IF depending on tissue.
Wash: 3 × 5–10 min in PBST/TBST between incubation steps.
pH/Ionic strength (general): Moderate ionic strength (100–200 mM salt) often improves specificity; avoid low-salt conditions that can increase background.
Additives (general): 10–50% glycerol is sometimes present for freeze protection in stock solutions; presence for this item is not specified. For live-cell applications, ensure preservative-free buffers.
Always verify compatibility with your detection system and sample type. For definitive, item-specific buffer recommendations, refer to the CoA/Spec Sheet.
Green Alternatives
For antibody products, "green" considerations focus on buffer composition, preservative choice, and packaging rather than solvent replacement.
Greener practices (general):
Preservatives: If azide-free formats are available, they can reduce aquatic toxicity risks during disposal; presence/availability for this item is not specified.
Glycerol content: Glycerol-free versions reduce carbon footprint from cryoprotectants and improve compatibility with mass spectrometry and conjugation workflows; item-specific formulation not specified.
Concentrate & aliquot to minimize plastic consumables by reducing freeze–thaw cycles and repeated pipetting.
Shipments consolidated and via reusable cold packs to reduce packaging waste; this item is shipped in an ice chest with ice pads per product data.
Comparative considerations (general):
Lyophilized format (when available) can reduce cold-chain energy usage; reconstitution details and availability for this item are not specified.
Always follow institutional waste disposal policies for proteinaceous materials and any preservatives present. Check the SDS/CoA for specific formulation to guide best environmental practices.
Pharmaceutical Uses
This product is designated for research use only and is not intended for human or veterinary use, diagnostic procedures, or as a therapeutic.
Formulation/excipient context: Monoclonal antibodies used in pharmaceutical manufacturing require GMP-grade production, defined excipient profiles, and validated viral clearance; no such claims are made for this item.
Possible laboratory-adjacent uses (general): Antibodies may serve as analytical reagents for in-process controls, identity testing, and potency assays in development settings; suitability of this specific mAb for regulated applications is not specified.
Pharmacopeial status: Not specified for this item; no USP/EP monograph applicability is claimed.
For any application beyond basic research, qualification and validation are required; consult the CoA/Spec Sheet and your QA unit.
Physical Properties
Antibody reagents are aqueous protein solutions or lyophilized solids rather than discrete small molecules.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Concentration / formulation: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight (literature, general for IgG): ~150 kDa for intact IgG; fragments (Fab ~50 kDa, F(ab')2 ~110 kDa) if applicable. Actual format for this product is not specified.
pI and charge (literature): Monoclonal IgGs typically have isoelectric points in the ~6–9 range, varying by sequence and glycosylation.
Solubility (general): Soluble in common biological buffers (e.g., PBS, TBS) across pH ~6.5–8.5; salting-out can occur at high ionic strength; denaturation/aggregation may occur with extreme pH, heat, or organic solvents.
Stability considerations (general):
Sensitive to repeated freeze–thaw, shear, and elevated temperature.
Aggregation promoted by interfaces (air–liquid), agitation, and high concentration without stabilizers.
Other physicochemical constants such as boiling point, melting point, density, refractive index, logP are not applicable to macromolecular antibody formulations.
Item-specific excipients (e.g., glycerol, BSA, azide) and exact pH: Not specified for this item; refer to CoA/Spec Sheet.
Quality and Grades
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Typical antibody quality attributes (general, for monoclonals):
Purity by SDS-PAGE (>90% for many research-grade IgGs); exact value for this item is not specified.
Binding specificity/affinity determined by ELISA, Western blot, IHC/IF titration (assay list not specified for this item).
Low endotoxin levels are relevant for cell-based assays; item-specific endotoxin value is not specified.
Host species: Mouse (per product name). Isotype, clonality (clone ID), and light chain type are not specified for this item.
Implications for use:
Research-grade antibodies are suitable for discovery and analytical applications (WB, IHC, IF, ELISA, IP/ChIP) when validated; consult datasheet for the exact tested applications and titers.
If a stabilizer (e.g., BSA, glycerol) is present, it can influence certain downstream applications (mass spectrometry, conjugation chemistry); presence/absence not specified here—verify on the CoA.
Documentation: For batch-specific validation, refer to the Certificate of Analysis and Specification Sheet.
Reaction and Applications
Chemical reaction applications (e.g., catalysis, organic synthesis) are not typically applicable to monoclonal antibodies supplied for analytical use. Instead, antibodies are used as affinity reagents in biochemical assays.
Relevant application domains (general):
Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF/ICC), ELISA, immunoprecipitation (IP), flow cytometry (FC), and immunocapture for proteomics.
Potential use in enzyme-based detection systems (HRP/AP if conjugated) or fluorescence detection (e.g., FITC/Alexa conjugates); conjugation state for this item is not specified.
Practical tips (general):
Validate antibody specificity with appropriate positive/negative controls and a secondary anti-mouse IgG when using unconjugated primaries.
Titrate to determine optimal dilution; start with a broad dilution series (e.g., 1:200–1:2000 for WB as a general range) and refine empirically.
Use gentle mixing and avoid vigorous vortexing to limit aggregation.
Item-specific tested applications and recommended dilutions are not provided; refer to the CoA/Spec Sheet for definitive guidance.
Reaction Conditions
Classical reaction-condition parameters (temperature, catalysts, yields) are not relevant to antibody affinity reagents. For assay conditions, only general guidance can be provided here.
Assay incubation (general):
WB primary incubation: 1–16 h at RT to 4°C; optimize dilution and time empirically.
IHC/IF primary incubation: 1–16 h at RT/4°C with appropriate blocking and permeabilization if needed.
ELISA coating and detection steps follow standard protocols; optimize antigen/antibody concentrations.
Temperature sensitivity: Avoid >37°C exposure unless explicitly validated; store and handle on ice as feasible during setup.
Item-specific, validated conditions and recommended dilutions are not provided in the product data; refer to the CoA/Spec Sheet for authoritative directions.
Safety and Handling
Safety profile for antibody research reagents is generally benign; however, always follow institutional biosafety practices.
GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to SDS.
Likely hazards (general): Protein solutions may contain preservatives (e.g., sodium azide) in some formulations; presence/absence for this item is not specified. Avoid skin/eye contact and ingestion. Treat as a potential biological material; avoid aerosol generation.
Recommended PPE (general): Lab coat, gloves (nitrile), and safety glasses. Handle in a clean area to prevent contamination.
Incompatibilities (general): Avoid strong oxidizers and proteases. Do not mix with reducing/denaturing agents unless intended (e.g., sample prep for SDS-PAGE). Avoid exposure to elevated temperature and extreme pH.
First aid (general): In case of skin/eye contact, rinse with water for several minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested, rinse mouth. Seek medical attention as per SDS guidance.
Special risks: Repeated freeze–thaw can lead to aggregation and loss of activity; aliquot upon first thaw. Use low-binding plasticware to minimize adsorption.
Authoritative source: Always defer to the product SDS and institutional EHS guidelines for definitive hazard and response information.
Solvent Selection
This product is an aqueous biological reagent; organic solvent selection is typically not applicable. Instead, buffer choice and additives govern performance.
Compatible media (general):
Phosphate-buffered saline (PBS) or Tris-buffered saline (TBS), pH ~7.2–7.6, are commonly used carriers for monoclonal antibodies.
Additives such as 0.01–0.1% Tween-20 (for WB/ELISA wash buffers) reduce nonspecific binding; 0.1–1% BSA or 1–5% nonfat dry milk often used as blocking agents. Presence of these in the product itself is not specified.
When to choose PBS vs TBS (general):
PBS is widely compatible; TBS is preferred when phospho-epitope detection in Western blot risks phosphate interference (case-dependent).
Avoid (general):
High concentrations of organic solvents (e.g., >10% methanol, DMSO) may denature antibodies unless protocol-mandated (e.g., methanol-fixed IF).
Extreme pH (<5 or >9) for prolonged periods can reduce binding capacity.
Item-specific formulation and recommended diluent: Not specified for this item; refer to CoA/Spec Sheet.
Storage and Reconstitution
Storage conditions (from product data): Store at -20°C. Avoid repeated freezing and thawing.
Shipping (from product data): Shipped in an ice chest with ice pads.
Aliquoting (general best practice): Upon first thaw, divide into single-use aliquots in low-bind tubes to minimize freeze–thaw cycles. Keep on ice during handling.
Short-term handling (general): Maintain at 2–8°C for working stocks used within a few days; return to -20°C (or per datasheet) for longer-term storage. Avoid frost-free freezers with temperature cycling.
Lyophilized vs liquid (item-specific status not specified):
If lyophilized: Reconstitute with sterile buffer (e.g., PBS) to the desired concentration; gently invert to dissolve; avoid vigorous vortexing. Exact reconstitution volume and buffer for this item are not specified; refer to CoA/Spec Sheet.
If supplied in liquid: Do not dilute the stock unless preparing working solutions; include carrier protein (e.g., BSA) if compatible to reduce adsorption; presence/absence of carriers in this item is not specified.
Light and agitation: Protect from strong light if conjugated to fluorophores (conjugation status not specified). Minimize agitation to avoid aggregation.
Documentation: For exact formulation, excipients (e.g., glycerol, BSA, sodium azide), concentration, and reconstitution instructions, consult the CoA/Spec Sheet.
Structure and Identity
Brief description: ACY3 Mouse mAb is a mouse-derived monoclonal antibody raised against the ACY3 antigen. Item-specific identifiers (CAS, InChIKey, SMILES) are not applicable to antibodies and are not provided.
SKU: Ab087343
Product name: ACY3 Mouse mAb (monoclonal antibody)
Antigen target: ACY3 (Aminoacylase-3) — antigen designation per product name; detailed epitope/region: Not specified for this item; refer to CoA/Spec Sheet.
Clone ID / Isotype: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not applicable for proteins (heterogeneous post-translational composition).
Molecular weight (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general, literature):
Typical IgG monoclonal architecture of ~150 kDa (literature), composed of two heavy chains (~50 kDa each) and two light chains (~25 kDa each) linked by disulfide bonds.
Y-shaped 2D depiction: Fc region (constant heavy chain domains) and two Fab arms (variable regions conferring antigen specificity).
Glycosylation commonly present on Fc (N-linked at CH2 domain), extent depends on production system (literature).
Sequence/epitope and species reactivity: Not specified for this item; refer to CoA/Spec Sheet.
Conjugation: Not specified for this item; refer to CoA/Spec Sheet.
Synthetic Utility
Not typically applicable. As a monoclonal antibody, this product is not a building block or reagent for chemical synthesis. It functions as an affinity reagent for detection, capture, or quantitation of the ACY3 protein.
If chemical conjugation is planned (general):
Antibodies can be derivatized via lysine (NHS ester chemistry) or cysteine residues (maleimide chemistry) to attach enzymes, fluorophores, or solid supports.
Buffer exchange into amine-free buffers (e.g., PBS without Tris) is typically required for NHS chemistry; reducing agents must be absent for maleimide coupling. Item-specific compatibility and formulation are not specified.
For purely synthetic chemistry applications, refer instead to small-molecule reagents and catalysts.
Target Specificity
Antigen/target details are required to define specificity for an antibody product.
Antigen name: ACY3 (from product name); epitope/peptide region: Not specified for this item; refer to CoA/Spec Sheet.
Clone ID and isotype: Not specified for this item; refer to CoA/Spec Sheet.
Species reactivity (tested): Not specified for this item; refer to CoA/Spec Sheet.
Cross-reactivity: Not specified for this item; refer to CoA/Spec Sheet.
Validated applications (WB, IHC, IF, ELISA, FC, IP): Not specified for this item; refer to CoA/Spec Sheet.
Until these parameters are confirmed on the datasheet/CoA, users should perform preliminary validation experiments with appropriate controls.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
